Hocus POCUS: a tool for increasing the efficiency of diagnosing venous thromboembolic disease in critically ill COVID-19 patients?

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON22592

Enrollment

Registered

2020-05-15

Start date

2020-05-15

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary embolism, deep venous thrombosis, venous thromboembolic disease, COVID-19

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: All patients with PCR confirmed COVID-19 with a clinically suspected pulmonary embolism, aged 18 years or over.

Exclusion criteria

Exclusion criteria: chronic and known deep vein thrombosis (DVT), ipsi- or contralateral DVT within the previous 6 months, pregnancy

Design outcomes

Primary

Measure	Time frame
The percentage of preventable CTPA in the work up of suspected PE in COVID-19 positive patients.	—

Secondary

Measure	Time frame
The percentage of preventable CTPA in the work up of suspected PE in COVID-19 positive patients. This percentage will be correlated to clinical parameters such as admission ward and early warning score.	—

Contacts

Public ContactDirk Tjwa

UMC Utrecht

dtjwa@umcutrecht.nl06-27744381

Outcome results